Clinical trial Recruiting at 1 site Interventional Ages 2 to 6

Cochlear implant for children with single-sided or asymmetric hearing loss

Official title: Evaluation of Cochlear Implantation in Unilateral or Asymmetric Hearing Loss in Children.

Run by Assistance Publique - Hôpitaux de Paris · NCT06930170 · Data updated 2026-11-12

This trial will test whether cochlear implants help children aged 4–6 with unilateral or asymmetric hearing loss improve speech understanding in noise and sound localization.

Quick facts

Study typeInterventional
Ages2 Years to 6 Years
SexAll
Enrollment36 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedSeptember 3, 2026
Main results expectedJanuary 2029
Study endsApril 2029
Registry record updatedOctober 22, 2026
Trial IDNCT06930170 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–6 who use spoken French and have severe-to-profound hearing loss in one ear with normal or only mild hearing in the other ear, with written consent from their legal guardians.

Probably not a fit

Children with bilateral hearing loss, severe neurological disorders, or those who already obtain good functional benefit from CROS/BAHA systems are unlikely to gain additional benefit from implantation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children aged 4–6 who speak French and have severe-to-profound unilateral or asymmetric hearing loss will be offered cochlear implantation with comparisons to conventional rerouting devices (CROS/BiCROS) when appropriate, and followed over time. Outcomes include speech perception in noise (FraSimat), sound localization (ERKI), and cortical auditory evoked potentials (PEAc), together with routine audiometry. Testing and surgery are performed at the Audiophonology Unit of Assistance Publique - Hôpitaux de Paris with scheduled pre- and post-implant assessments. The protocol seeks to show whether implantation can restore aspects of binaural hearing not achievable with CROS or BAHA devices.

Why it matters

Potential benefit: If successful, the implant could restore contralateral auditory input and improve speech understanding in noise, sound localization, and downstream language and school performance.

How similar studies have gone: Adult studies have demonstrated improved speech-in-noise performance and localization with cochlear implants, and pediatric data are promising but still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child aged 2 to 6 years at the time of inclusion
* Using spoken French as the primary mode of communication
* Diagnosed with unilateral or asymmetric hearing loss :

Unilateral is defined by severe to profound hearing loss in the affected ear (thresholds \> 70 dB at ≥ 4 frequencies, established by audiometry or ASSR) and normal hearing in the better ear (thresholds ≤ 25 dB between 500-4000 Hz, established by audiometry or ASSR).

Asymmetric is defined by severe to profound hearing loss in the weaker ear (thresholds \> 70 dB at ≥ 4 frequencies, established by audiometry or ASSR) and mild hearing loss in the better ear (thresholds between 30-40 dB at ≤ 4 frequencies, established by audiometry or ASSR).

* Written informed consent from both legal guardians (or the sole guardian, if applicable)
* Affiliated with a health insurance system or entitled to coverage

Exclusion Criteria:

* Severe neurological disorder, identified by MRI and/or a neuro-pediatric assessment
* Severe cognitive, child psychiatric, or developmental delay
* Severe cochleo-vestibular malformation
* Severe cochlear nerve malformation
* Social circumstances preventing long-term follow-up
* Family not proficient in spoken French
* Patient fitted with a CROS or BiCROS system
* Patient with a contraindication to implantation surgery or anesthesia (including lack of meningitis/pneumococcal vaccination)

Where it's running

  • Audiophonology Unit of the Ear, Nose and Throat (ENT) Department ("Oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale")
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.